Cancer-killing drug approved, but will you be able to afford it?

01 September 2017, 01:34 | Robert Harris

Novartis' CAR-T gene therapy, the first approved by FDA, to be priced based on cancer patients' outcomes

This undated image made available by Novartis on Wednesday Aug. 31 2017 shows an IV bag of their drug Kymriah. On Wednesday the Food and Drug Administration approved this first treatment that genetically engineers patients own blood cells to seek and

Truly today's approval of the gene therapy by FDA is a milestone in the treatment of leukemia and it is expected that treatment becomes successful on long term basis.

The new treatment modifies patients' own immune T cells, which are collected and reprogrammed at the Novartis manufacturing facility to potentially seek and destroy the patients' leukemia cells.

The new treatment is the first USA approval of a treatment for genetic modification, and its maker promises some unprecedented pricing options- including offering it for free if it doesn't work quickly.

Gene therapy has been heralded as a powerful new weapon in the fight against cancer with some experts even claiming that eventually it could signal the end of the disease.

While 95 percent or more of children newly diagnosed with ALL can reach remission with standard therapy, between 10 and 15 percent of those children ultimately relapse within five years of being diagnosed.

The approval of Novartis' CAR-T therapy comes just two days after Gilead Sciences Inc. announced an agreement to spend $11.9 billion and buy Kite Pharma Inc., which is developing its own CAR-T therapy scheduled for an FDA ruling by November 29.

The Food and Drug Administration has approved a new kind of cancer treatment in what it called a "historic action".

Doctors remove T cells from each cancer victim and ship the material to its factory in Morris Plains, New Jersey.

Novartis' CAR-T gene therapy, the first approved by FDA, to be priced based on cancer patients' outcomes
FDA Approves CAR T-Cell Therapy for Leukemia

The high cost of the therapy reflects the fact that the CAR-T procedure is fairly intensive. "The lessons learned from the clinical trials of vehicle T-cell operations will assist us in being able to provide to the larger population".

"The FDA is requiring that hospitals and their associated clinics that dispense Kymriah be specially certified", it added. Based on those results, an FDA advisory panel recommended the approval in July.

Shares of Juno Therapeutics Inc, which a year ago reported a handful of patient deaths during trials of its CAR-T therapy, were down 8.9 percent at $39.92.

The firm also highlighted the "urgent need" for new treatment options that boost outcomes for patients with relapsed or refractory (r/r) B-cell precursor ALL, whose prognosis is poor.

The price of the therapy is tagged at around $500,000.

Kymriah will carry a boxed warning because of the treatment's potential to cause deadly side effects, including neurological complications and what's known as cytokine release syndrome, a systemic reaction triggered by the destruction of the cancer cells.

Questions also remain about the drug's possible long-term side effects and ability to prevent ALL from coming back. The treatment costs $475,000. "While payers are developing their coverage policies for [tisagenlecleucel], we will offer an access program in the United States for eligible uninsured or underinsured patients". "The established path to commercialization taken by Novartis will provide considerable motivation for cell therapy scientists and development companies as well as investors looking to benefit from the ongoing success in the industry".

Milwaukee County Sheriff David Clarke has resigned
He was hit by allegations in May that he plagiarized content in his master's thesis on homeland security, which he denied. In January, after four inmate deaths in county jails, County Supervisor Supreme Moore Omokunde urged Clarke to resign.

Sean Spicer Finally Got to Meet Pope Francis, No Thanks to Trump
In a photo published to Vatican Radio's Facebook page , you can see Spicer snapping a picture of the Catholic leader. The group was granted an audience with Pope Francis , fulfilling a lifelong wish for the ex-press secretary.

Mayweather refused last-minute prop wagers on fight with McGregor
With post on his social media accounts, dos Anjos called McGregor "McChicken" in the first of many hashtags. Why Snoop? We know you like Mayweather and the Money team, but this was something shameful.



Other News

Trending Now

Blade Runner 2049 Short Reveals Backstory for Jared Leto's Wallace
The movie also stars Rutger Hauer, Sean Young, Edward James Olmos, Daryl Hannah, Joanna Cassidy, William Sanderson, M. In addition to his scientific breakthroughs, he broke barriers by creating newer, more obedient Replicants.

Fox News pulls its programming in the United Kingdom due to low ratings
Opponents of the deal have also expressed fears that the rightward-tilt of Fox News editorial content could seep into Sky News. Opponents of Fox's purchase of Sky have argued that the network's right-wing leanings represent a bias in their news coverage.

Detroit Lions and Matthew Stafford agree on contract extension
Stafford's market-setting contract could also have ramifications for the Patriots' future financial decisions at quarterback . Sources say Stafford's deal includes a record $92 million guarantee, including a $50 million signing bonus.

Amazon cuts prices on items at Whole Foods
But one other big change within Whole Foods locations might be just as important - if not more so - than those other factors. Amazon says there'll be immediate price cuts on many grocery staples including vegetables, fruit, fish, meat and eggs.

Fitbit's Ionic smartwatch wants to be the ultimate fitness wearable
Fitbit showed it was ready for a market-share fight with the debut of what it's calling its first smart watch, the Fitbit Ionic . Ionic launches with four main partners: Pandora , AccuWeather, Starbucks mobile payments and a Strava activity tracking app.

Transgender service members sue Trump administration for violating the constitution
The lawsuit argues the service ban violates the constitutional guarantees of equal protection and substantive due process. Studies and advocates place the number of trans people now serving in the armed forces between 1,300 and 11,000.

Assembly bypolls: Counting of votes today; all eyes on Panaji, Bawana
With 16167 votes, Vishwajit Rane beat Congress candidate Roy Naik, who received 6101 votes after total four rounds of counting. AAP candidate Ram Chandra, CM Arvind Kejriwal and other ministers of the Delhi government had all campaigned in Bawana.

Facebook and Instagram 'crash' for thousands of internet users
Users were unable to login to their accounts while some faced issues with sharing pictures or other posting statuses. Here is a compilation of some of the best tweets to come out of the trending #facebookdown on Twitter this morning.

Qatar Restores Iran Ties
Al-Sulaiti returned to the Iranian capital on Friday after a 20-month hiatus that started in January 2016. Qatar will reinstate its diplomatic relationship with Iran, its foreign ministry announced Thursday.

Game of Thrones Season 7 Finale Running Time & Title Revealed
While nothing major is revealed here, the focus is put on Jon and Tyrion meeting with Cersei and Jaime in King's Landing. Beyond the Wall , Jon Snow tried to return Longclaw to Ser Jorah Mormont since it belonged to the Mormont family.